
Semax
ACTH-derived peptide studied for brain-cell support, learning, and stress response.
For Research Use Only
Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.
The lower price is applied automatically once your cart holds 5 or more of this vial.
Bacteriostatic water included
About this peptide
Semax is a synthetic peptide derived from a fragment of the natural hormone ACTH. It is widely investigated for its neuroprotective and cognitive effects, particularly its ability to upregulate key brain neurotrophic factors like BDNF and NGF that help nerve cells survive, adapt, and form new connections. In research protocols, scientists explore Semax for its potential to support sharpened focus, memory retention, healthy cerebral blood flow, and resistance to mental fatigue.
Why researchers reach for Semax
BDNF upregulation
Referenced across rodent hippocampal expression studies.
Neuroprotective models
Explored in ischemia and cognitive stress paradigms.
Melanocortin lineage
Non-hormonal ACTH(4-10) fragment analogue.
Key features
- ≥99% HPLC purity
- ACTH(4-10) heptapeptide analogue
- Mass-spec verified
- Cold-chain dispatch
How it works
Neurotrophin induction
Increases BDNF and NGF expression in vitro.
Monoamine modulation
Alters dopamine and serotonin turnover in rodent brain.
Enkephalin activity
Inhibits enkephalin degradation, extending endogenous signaling.
Research dosage guidelines
Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.
| Range | Reported dose | Note |
|---|---|---|
| Typical reconstitution | 2 mL bacteriostatic water | Yields 5 mg/mL (5000 mcg/mL) |
| Reported research range | 200–600 mcg/day | Reference only |
Tracking this compound? Registered researchers can log active Semax protocols in their private Research Log.
Timing in research protocols
Intranasal, split across the day, in defined courses rather than continuously.
- The most cited clinical work (Gusev and Martynov, 2018, post-stroke) used 6,000 mcg per day intranasally in two 10-day courses separated by a 20-day interval.
- Daytime split dosing reflects rapid intranasal absorption and a short duration of action.
- The 10-days-on, several-weeks-off course structure recurs throughout the Russian nootropic-peptide literature.
- No meal relationship is reported in the primary studies.
Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.
Technical specifications
- Sequence
- Met-Glu-His-Phe-Pro-Gly-Pro
- Molecular weight
- 813.9 g/mol
- Purity
- ≥99% (HPLC)
- Form
- Lyophilized powder
- Vial size
- 10 mg
- Storage (lyophilised vial)
- Cool, dry and protected from light
- Storage (after reconstitution)
- 2–8°C
Published research
Peer-reviewed literature on Semax. Links open in a new tab.
Research use notice
Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.
